Senju Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Senju Pharmaceutical Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013213
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Senju Pharmaceutical Co Ltd (Senju) researches, develops, manufactures and markets pharmaceutical products for eye, ear, nose, throat, and skin. The company offers a wide range of ophthalmological products. Its product portfolio includes prescription products, OTC medicines and veterinary drugs. Senju offers prescription products in the areas of inflammation, allergy, glaucoma, cataract, protection of cornea, infection and surgical aid. Its OTC medicines include ophthalmological drugs such as eye drops, contact lens preparations and eye solutions; and animal science drugs include both animal pharmaceuticals and aqua products. It operates research laboratories and manufacturing facilities in Japan and the US. The company exports its products in Asia, North and South America, Europe and Middle East. Senju is headquartered in Chuo-ku, Osaka, Japan.

Senju Pharmaceutical Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Senju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Senju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Senju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Senju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Senju Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Senju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Senju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Gene Techno Science Enters into Co-Development Agreement with Senju Pharma 11
Licensing Agreements 12
InSite Vision Enters into Licensing Agreement with Senju Pharma for Azithromycin Ophthalmic Solution 12
Allegro Ophthalmics Enters Into Licensing Agreement With Senju Pharma To Develop Integrin Peptide Therapy 13
Senju Pharmaceutical Co Ltd – Key Competitors 14
Senju Pharmaceutical Co Ltd – Key Employees 15
Senju Pharmaceutical Co Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Senju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Senju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Senju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Senju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Senju Pharmaceutical Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Senju Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Senju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Gene Techno Science Enters into Co-Development Agreement with Senju Pharma 11
InSite Vision Enters into Licensing Agreement with Senju Pharma for Azithromycin Ophthalmic Solution 12
Allegro Ophthalmics Enters Into Licensing Agreement With Senju Pharma To Develop Integrin Peptide Therapy 13
Senju Pharmaceutical Co Ltd, Key Competitors 14
Senju Pharmaceutical Co Ltd, Key Employees 15
Senju Pharmaceutical Co Ltd, Other Locations 16
Senju Pharmaceutical Co Ltd, Subsidiaries 16

★海外企業調査レポート[Senju Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Transportes Aereos Portugueses, SGPS, SA:企業の戦略・SWOT・財務情報
    Transportes Aereos Portugueses, SGPS, SA - Strategy, SWOT and Corporate Finance Report Summary Transportes Aereos Portugueses, SGPS, SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Madhya Pradesh Power Generating Company Ltd:企業の発電所・SWOT分析2018
    Madhya Pradesh Power Generating Company Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, info …
  • Cassa Depositi e Prestiti SpA:石油・ガス:M&Aディール及び事業提携情報
    Summary Cassa Depositi e Prestiti SpA (CDP) is a financial service provider that offers banking and financial services. The company offers loans to state and regional governments, public bodies, local authorities, and public-law entities through postal savings products under state guarantee and the …
  • Panoramic Universal Limited:企業の戦略・SWOT・財務分析
    Panoramic Universal Limited - Strategy, SWOT and Corporate Finance Report Summary Panoramic Universal Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Granules India Ltd (GRANULES):企業の財務・戦略的SWOT分析
    Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • H.B. Fuller Co (FUL):企業の財務・戦略的SWOT分析
    H.B. Fuller Co (FUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • 3M India Limited (3MINDIA):企業の財務・戦略的SWOT分析
    3M India Limited (3MINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SJVN Ltd (SJVN):企業の財務・戦略的SWOT分析
    SJVN Ltd (SJVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Kellogg Co:戦略・SWOT・企業財務分析
    Kellogg Co - Strategy, SWOT and Corporate Finance Report Summary Kellogg Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • HD Supply Inc (HDS):企業の財務・戦略的SWOT分析
    HD Supply Inc (HDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Downer EDI Ltd (DOW):企業の財務・戦略的SWOT分析
    Downer EDI Ltd (DOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Engie SA (ENGI):企業の財務・戦略的SWOT分析
    Engie SA (ENGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Immune Pharmaceuticals Inc (IMNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Immune Pharmaceuticals Inc (Immune Pharma), formerly EpiCept Corp is a drug development company that develops novel therapies for immunologic and inflammatory diseases. The company’s pipeline products include Bertilimumab and Nanocyclo. Its Bertilimumab is a human monoclonal antibody designe …
  • Strategic Oil & Gas Ltd (SOG):企業の財務・戦略的SWOT分析
    Summary Strategic Oil & Gas Ltd (Strategic Oil & Gas) is an upstream oil and gas exploration and development company. The company acquires, explores, operates, manages, and develops crude oil and natural gas assets. It holds interests and operates its oil and gas exploration projects such as Marlowe …
  • Municipal Energy Agency of Nebraska:企業の発電所・SWOT分析2018
    Municipal Energy Agency of Nebraska - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Celestica Inc.:企業の戦略・SWOT・財務情報
    Celestica Inc. - Strategy, SWOT and Corporate Finance Report Summary Celestica Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Qenos Pty Ltd:企業の戦略的SWOT分析
    Qenos Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Compagnie Generale des Etablissements Michelin:企業の戦略・SWOT・財務分析
    Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report Summary Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Veolia Environnement SA (VIE):電力:M&Aディール及び事業提携情報
    Summary Veolia Environnement SA (Veolia) is an environmental management services company that designs and offers water, waste and energy management solutions. Its service offerings include wastewater and sanitation services, drinking water treatment and distribution and waste management and energy s …
  • AIA Group Limited:企業の戦略・SWOT・財務情報
    AIA Group Limited - Strategy, SWOT and Corporate Finance Report Summary AIA Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆